These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 549003)

  • 61. Acute epidemic aluminium osteomalacia secondary to water supply contamination.
    O'Brien AA; Moore DP; Keogh JA
    Ir J Med Sci; 1990 Mar; 159(3):71-3. PubMed ID: 2361822
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bone scan in haemodialysis patients: relation to hyperparathyroidism and aluminium toxicity.
    Tielemans C; Wens R; Collart F; Dratwa M; Smeyers-Verbeke J; Van Hooff I; De Roy G; Bergmann P; Verbeelen D
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():399-402. PubMed ID: 3991531
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aluminium toxicity during regular haemodialysis.
    Elliott HL; Dryburgh F; Fell GS; Sabet S; Macdougall AI
    Br Med J; 1978 Apr; 1(6120):1101-3. PubMed ID: 638617
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aluminium and bone disease in chronic renal failure.
    Malluche HH
    Nephrol Dial Transplant; 2002; 17 Suppl 2():21-4. PubMed ID: 11904354
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aluminium intoxication in renal disease.
    Kerr DN; Ward MK; Ellis HA; Simpson W; Parkinson IS
    Ciba Found Symp; 1992; 169():123-35; discussion 135-41. PubMed ID: 1490419
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnosis and treatment of aluminium bone disease.
    D'Haese PC; Couttenye MM; De Broe ME
    Nephrol Dial Transplant; 1996; 11 Suppl 3():74-9. PubMed ID: 8840316
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dose-response relationships in aluminium toxicity in humans.
    Coulson JM; Hughes BW
    Clin Toxicol (Phila); 2022 Apr; 60(4):415-428. PubMed ID: 35179097
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Haemodialysis related osteomalacia: a staining method to demonstrate aluminium.
    Buchanan MR; Ihle BU; Dunn CM
    J Clin Pathol; 1981 Dec; 34(12):1352-4. PubMed ID: 6173400
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Correlation of serum aluminum values with tissue aluminum concentration.
    De Broe ME; Van de Vyver FL; Bekaert AB; D'Haese P; Paulus GJ; Visser WJ; Van Grieken R; de Wolff FA; Verbueken AH
    Contrib Nephrol; 1984; 38():37-46. PubMed ID: 6713899
    [No Abstract]   [Full Text] [Related]  

  • 70. Aluminium bone disease in patients receiving plasma exchange with contaminated albumin.
    Maharaj D; Fell GS; Boyce BF; Ng JP; Smith GD; Boulton-Jones JM; Cumming RL; Davidson JF
    Br Med J (Clin Res Ed); 1987 Sep; 295(6600):693-6. PubMed ID: 3117305
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aluminium retention and toxicity in chronic renal failure.
    Thurston H; Gilmore GR; Swales JD
    Lancet; 1972 Apr; 1(7756):881-3. PubMed ID: 4111831
    [No Abstract]   [Full Text] [Related]  

  • 72. Accumulation of aluminium in chronic renal failure due to administration of albumin replacement solutions.
    Maher ER; Brown EA; Curtis JR; Phillips ME; Sampson B
    Br Med J (Clin Res Ed); 1986 Feb; 292(6516):306. PubMed ID: 3080148
    [No Abstract]   [Full Text] [Related]  

  • 73. Rapid alterations in plasma aluminium in association with varied oral aluminium intake in dialysis patients.
    Boyce NW; Holdsworth SR; Thomson NM; Atkins RC
    Nephron; 1987; 45(2):164. PubMed ID: 3561627
    [No Abstract]   [Full Text] [Related]  

  • 74. Plasma aluminium in a reference population: the effects of antacid consumption and its influence on biochemical indices of bone formation.
    Sharp CA; Perks J; Worsfold M; Day JP; Davie MW
    Eur J Clin Invest; 1993 Sep; 23(9):554-60. PubMed ID: 8243526
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum aluminium concentration and aluminium deposits in bone in patients receiving hemodialysis.
    Charhon S; Meunier PJ
    Br Med J (Clin Res Ed); 1985 Sep; 291(6497):735-6. PubMed ID: 3929918
    [No Abstract]   [Full Text] [Related]  

  • 76. Phosphate removal using hollow fibers containing aluminium oxide.
    Walker J; Brancaccio D; Galmozzi C; Tessore V; Denti E
    Minerva Nefrol; 1979; 26(3):437-40. PubMed ID: 262290
    [No Abstract]   [Full Text] [Related]  

  • 77. Vanadium in patients undergoing chronic haemodialysis.
    Hosokawa S; Yoshida O
    Nephrol Dial Transplant; 1989; 4(4):282-4. PubMed ID: 2502735
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Aluminum accumulation in patients with chronic renal disease.
    Quarles LD; Drezner MK
    N Engl J Med; 1991 Jul; 325(3):208-9. PubMed ID: 1888376
    [No Abstract]   [Full Text] [Related]  

  • 79. Gastrointestinal absorption of aluminium in chronic renal insufficiency.
    Knoll O; Kellinghaus H; Bertram HP; Zumkley H; Graefe U
    Contrib Nephrol; 1984; 38():24-31. PubMed ID: 6713897
    [No Abstract]   [Full Text] [Related]  

  • 80. [Bone changes in chronic renal failure].
    Sakuyama K; Ishikawa T; Fujikawa M; Mitsuda K
    Rinsho Hoshasen; 1971 Nov; 16(11):909-21. PubMed ID: 5211327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.